HOME >> BIOLOGY >> NEWS
Epigenetic drugs, promising for breast cancer treatment

Worldwide, cancer persists as one of the most important diseases that affect the human being. The knowledge on the molecular bases of cancer generated during the last decades has been successfully translated into small but significant gains in overall cancer survival rates due to better primary prevention measures, improved diagnostic methods and the development of more effective and specific therapies, collectively termed "molecular targeted therapies". In the context of these new forms of treatment, epigenetic or transcriptional cancer therapy is clearly promising.

Epigenetics refers to the function of DNA that does not depend on the coding DNA sequence itself but on the accessory molecules and mechanisms affected by DNA. It is known that epigenetic alterations are equally if not more important than classical genetic alterations to disrupt the function of tumour suppressor genes. The two most studied epigenetic aberrations common to all types of cancer are DNA hypermethylation and histone deacetylation, which cooperate to silence the expression of tumour suppressor genes, just as gene mutations and gene deletions do. The big difference between these two alternative ways that tumour cells use to inactivate tumour suppressor genes is that, while the reversal of genetic alterations is technically almost unfeasible in clinical scenarios, the function of these epigenetically inactivated suppressor genes is easily reactivated by pharmacological means. In this inaugural issue of PLoS ONE, Dr. Dueas-Gonzalez's group from the Instituto de Investi gaciones Biomdicas of the Universidad Nacional Autnoma de Mxico and the Instituto Nacional de Cancerologa, Mexico, demonstrate, for the first time, that a combination of a DNA methylation and a histone deacetylase inhibitor, can reactivate the expression of more than a thousand genes in primary tumours of breast cancer patients.

Among these reactivated genes are those implicated in the regulation of cell pr
'"/>

Contact: Rosalba Namihira
namihira@biomedicas.unam.mx
52-155-297-22352
Public Library of Science
20-Dec-2006


Page: 1 2 3

Related biology news :

1. Epigenetic studies will provide a better understanding of disease
2. Epigenetics to shape stem cell future
3. New view of cancer: Epigenetic changes come before mutations
4. Epigenetic activity silences Rb2/P130 gene in lung cancer
5. A new plant-bacterial symbiotic mechanism promising
6. A new plant-bacterial symbiotic mechanism promising for crop applications
7. American Association for Cancer Research provides support for promising cancer scientists
8. Sea creatures toxin could lead to promising cancer treatment
9. New study suggests promising drug combinations for sleeping sickness
10. Analysis of breast-cancer gene role offers promising target
11. Researchers report initial success in promising approach to prevent tooth decay

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/17/2019)... (PRWEB) , ... July 16, 2019 , ... Imagine using ... or to detect bone loss before it causes osteoporosis. For South Dakota School of ... “This is potentially a game-changer in terms of our ability to monitor and prevent ...
(Date:7/9/2019)... ... July 09, 2019 , ... Murrieta Genomics, ... its incubator program. The founder and CEO of Tx Genetic, Helen Harrison, has ... those suffering from epithelial connective tissue disorders. , “We are pleased and excited ...
(Date:7/5/2019)... ... July 05, 2019 , ... ... bring its patented Tractus™ Platform to governments around the world. , Powered ... technology and point of care solutions to operating theatres worldwide to address new ...
Breaking Biology News(10 mins):
(Date:7/9/2019)... ... 2019 , ... Today, at the BIO World Congress on Industrial ... (NCGA) announced the winners of the Consider Corn Challenge II. Three winners were chosen, ... to produce biobased materials. , “Corn is a sustainable, abundant and affordable ...
(Date:6/18/2019)... ... June 18, 2019 , ... Personalized Stem Cells, Inc (“PSC”), ... to the FDA for use of a person’s own adipose-derived stem cells to treat ... in the knee. This IND is the first of several planned clinical trials ...
(Date:6/11/2019)... ... June 11, 2019 , ... Mytonomy, ... a national leader in opioid treatment, announced today they are partnering to combat ... Mytonomy recently deployed its virtual care platform at the Mayo Clinic to drive ...
(Date:5/31/2019)... Redwood City, California (PRWEB) , ... ... ... received allowance of our patent applications from the USPTO providing proprietary interest ... SYSTEM AND METHOD FOR SLEEP DISORDER DIAGNOSIS AND TREATMENT… extends Somnology’s IP ...
Breaking Biology Technology:
Cached News: